Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Diagnosing enterovirus meningitis via blood transcriptomics: an alternative for lumbar puncture?

Bartholomeus E, De Neuter N, Lemay A, Pattyn L, Tuerlinckx D, Weynants D, Van Lede K, van Berlaer G, Bulckaert D, Boiy T, Vander Auwera A, Raes M, Van der Linden D, Verhelst H, Van Steijn S, Jonckheer T, Dehoorne J, Joos R, Jansens H, Suls A, Van Damme P, Laukens K, Mortier G, Meysman P, Ogunjimi B.

J Transl Med. 2019 Aug 23;17(1):282. doi: 10.1186/s12967-019-2037-6.

2.

Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial.

Mallalieu NL, Wimalasundera S, Hsu JC, Douglass W, Wells C, Penades IC, Cuttica R, Huppertz HI, Joos R, Kimura Y, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Wouters C.

Pediatr Rheumatol Online J. 2019 Aug 22;17(1):57. doi: 10.1186/s12969-019-0364-z.

3.

Relationship Between the Degree of Iris Pigmentation and Corneal Sensitivity to a Cooling Stimulus.

Ntola AM, Nosch DS, Joos RE, Murphy PJ.

Cornea. 2019 Jun;38(6):674-683. doi: 10.1097/ICO.0000000000001933.

PMID:
30964757
4.

Resilience Factors in Children with Juvenile Idiopathic Arthritis and Their Parents: The Role of Child and Parent Psychological Flexibility.

Beeckman M, Hughes S, Van Ryckeghem D, Van Hoecke E, Dehoorne J, Joos R, Goubert L.

Pain Med. 2019 Jun 1;20(6):1120-1131. doi: 10.1093/pm/pny181.

PMID:
30256982
5.

Perinuclear antineutrophil cytoplasmic antibody-positive vasculitis, oligoarthritis, tendinitis, and myositis associated with isotretinoin in a 15-year-old boy: Case report and review of literature.

Mangodt TC, Joos R, Siozopoulou V, Cortoos PJ, Baeten H, Docx M, van den Akker M.

Pediatr Dermatol. 2018 May;35(3):e173-e177. doi: 10.1111/pde.13445. Epub 2018 Apr 11. Review.

PMID:
29644707
6.

The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Dehoorne J, Joos R, Wouters C, Swart JF, Consolaro A, Bovis F, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):187-194. doi: 10.1007/s00296-018-3935-2. Epub 2018 Apr 7.

7.

Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.

Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Berman A, Calvo Penadés I, Antón J, Ávila-Zapata F, Cuttica R, Horneff G, Foeldvari I, Keltsev V, Kingsbury DJ, Viola DO, Joos R, Lauwerys B, Paz Gastañaga ME, Rama ME, Wouters C, Bohnsack J, Breedt J, Fischbach M, Lutz T, Minden K, Miraval T, Ally MMTM, Rubio-Pérez N, Solau Gervais E, van Zyl R, Li X, Nys M, Wong R, Banerjee S, Lovell DJ, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Arthritis Rheumatol. 2018 Jul;70(7):1144-1154. doi: 10.1002/art.40466. Epub 2018 May 20.

8.

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.

Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, Abud-Mendoza C, Reiff A, Alexeeva E, Rubio-Pérez N, Keltsev V, Kingsbury DJ, Del Rocio Maldonado Velázquez M, Nikishina I, Silverman ED, Joos R, Smolewska E, Bandeira M, Minden K, van Royen-Kerkhof A, Emminger W, Foeldvari I, Lauwerys BR, Sztajnbok F, Gilmer KE, Xu Z, Leu JH, Kim L, Lamberth SL, Loza MJ, Lovell DJ, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Ann Rheum Dis. 2018 Jan;77(1):21-29. doi: 10.1136/annrheumdis-2016-210456. Epub 2017 May 15.

9.

ASAS definition for sacroiliitis on MRI in SpA: applicable to children?

Herregods N, Dehoorne J, Van den Bosch F, Jaremko JL, Van Vlaenderen J, Joos R, Baraliakos X, Varkas G, Verstraete K, Elewaut D, Jans L.

Pediatr Rheumatol Online J. 2017 Apr 11;15(1):24. doi: 10.1186/s12969-017-0159-z.

10.

Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy.

Brachat AH, Grom AA, Wulffraat N, Brunner HI, Quartier P, Brik R, McCann L, Ozdogan H, Rutkowska-Sak L, Schneider R, Gerloni V, Harel L, Terreri M, Houghton K, Joos R, Kingsbury D, Lopez-Benitez JM, Bek S, Schumacher M, Valentin MA, Gram H, Abrams K, Martini A, Lovell DJ, Nirmala NR, Ruperto N; Pediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).

Arthritis Res Ther. 2017 Jan 23;19(1):13. doi: 10.1186/s13075-016-1212-x.

11.

Diagnostic Value of MRI of the Sacroiliac Joints in Juvenile Spondyloarthritis.

Herregods N, Dehoorne J, Jaremko J, Joos R, Baraliakos X, Verstraete K, Jans L.

J Belg Soc Radiol. 2016 Nov 19;100(1):95. doi: 10.5334/jbr-btr.1198.

12.

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.

Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18.

PMID:
27432356
13.

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.

Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Brochard K, Corona F, Dressler F, Gerloni V, Apaz MT, Bracaglia C, Cespedes-Cruz A, Cimaz R, Couillault G, Joos R, Quartier P, Russo R, Tardieu M, Wulffraat N, Bica B, Dolezalova P, Ferriani V, Flato B, Bernard-Medina AG, Herlin T, Trachana M, Meini A, Allain-Launay E, Pilkington C, Vargova V, Wouters C, Angioloni S, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO).

Lancet. 2016 Feb 13;387(10019):671-8. doi: 10.1016/S0140-6736(15)01021-1. Epub 2015 Nov 30.

PMID:
26645190
14.

Diagnositic value of pelvic enthesitis on MRI of the sacroiliac joints in enthesitis related arthritis.

Herregods N, Dehoorne J, Pattyn E, Jaremko JL, Baraliakos X, Elewaut D, Van Vlaenderen J, Van den Bosch F, Joos R, Verstraete K, Jans L.

Pediatr Rheumatol Online J. 2015 Nov 10;13(1):46. doi: 10.1186/s12969-015-0045-5.

15.

Diagnostic value of MRI features of sacroiliitis in juvenile spondyloarthritis.

Herregods N, Dehoorne J, Joos R, Jaremko JL, Baraliakos X, Leus A, Van den Bosch F, Verstraete K, Jans L.

Clin Radiol. 2015 Dec;70(12):1428-38. doi: 10.1016/j.crad.2015.09.003. Epub 2015 Oct 23.

PMID:
26481251
16.

Effects of Prism Eyeglasses on Objective and Subjective Fixation Disparity.

Schroth V, Joos R, Jaschinski W.

PLoS One. 2015 Oct 2;10(10):e0138871. doi: 10.1371/journal.pone.0138871. eCollection 2015.

17.

Blink Animation Software to Improve Blinking and Dry Eye Symptoms.

Nosch DS, Foppa C, Tóth M, Joos RE.

Optom Vis Sci. 2015 Sep;92(9):e310-5. doi: 10.1097/OPX.0000000000000654.

PMID:
26164310
18.

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Van der Elst K, Meyfroidt S, Westhovens R; CareRA study group.

Arthritis Res Ther. 2015 Apr 9;17:97. doi: 10.1186/s13075-015-0611-8.

19.

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.

Ann Rheum Dis. 2015 Jan;74(1):27-34. doi: 10.1136/annrheumdis-2014-205489. Epub 2014 Oct 30.

PMID:
25359382
20.

Towards laparoscopic tissue aspiration.

Hollenstein M, Bugnard G, Joos R, Kropf S, Villiger P, Mazza E.

Med Image Anal. 2013 Dec;17(8):1037-45. doi: 10.1016/j.media.2013.06.001. Epub 2013 Jun 19.

PMID:
23876854
21.

The accuracy of dynamic contour tonometry over soft contact lenses.

Gogniat F, Steinegger D, Nosch DS, Joos R, Goldschmidt M.

Optom Vis Sci. 2013 Feb;90(2):125-30. doi: 10.1097/OPX.0b013e31827cdaa7.

PMID:
23292044
22.

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802. Erratum in: N Engl J Med. 2015 Feb 26;372(9):887.

23.

Oral apremilast in the treatment of active psoriatic arthritis: results of a multicenter, randomized, double-blind, placebo-controlled study.

Schett G, Wollenhaupt J, Papp K, Joos R, Rodrigues JF, Vessey AR, Hu C, Stevens R, de Vlam KL.

Arthritis Rheum. 2012 Oct;64(10):3156-67. doi: 10.1002/art.34627.

24.

Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics.

Joos R, Dehoorne J, Hoffman I, Mielants H, Verbruggen G, Elewaut D.

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):870-6.

PMID:
19917176
25.

Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.

Apaz MT, Saad-Magalhães C, Pistorio A, Ravelli A, de Oliveira Sato J, Marcantoni MB, Meiorin S, Filocamo G, Pilkington C, Maillard S, Al-Mayouf S, Prahalad S, Fasth A, Joos R, Schikler K, Mozolova D, Landgraf JM, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation.

Arthritis Rheum. 2009 Apr 15;61(4):509-17. doi: 10.1002/art.24343.

26.

Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.

Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D.

Ann Rheum Dis. 2009 Mar;68(3):412-5. doi: 10.1136/ard.2008.094813. Epub 2008 Oct 17.

PMID:
18930995
27.

Hippocampal atrophy and developmental regression as first sign of linear scleroderma "en coup de sabre".

Verhelst HE, Beele H, Joos R, Vanneuville B, Van Coster RN.

Eur J Paediatr Neurol. 2008 Nov;12(6):508-11. doi: 10.1016/j.ejpn.2007.12.001. Epub 2008 Jan 22.

PMID:
18207439
28.

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.

Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH; Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group.

Arthritis Rheum. 2007 Sep;56(9):3096-106.

29.

Expressive dimensions of pain catastrophizing: a comparative analysis of school children and children with clinical pain.

Vervoort T, Craig KD, Goubert L, Dehoorne J, Joos R, Matthys D, Buysse A, Crombez G.

Pain. 2008 Jan;134(1-2):59-68. Epub 2007 May 9.

PMID:
17493753
30.

Low magnetic moment PIN diodes for high field MRI surface coils.

Voskoboynik P, Joos RD, Doherty WE Jr, Goldfarb RB.

Med Phys. 2006 Dec;33(12):4499-501.

PMID:
17278801
31.

Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study.

Oliveira S, Ravelli A, Pistorio A, Castell E, Malattia C, Prieur AM, Saad-Magalhães C, Murray KJ, Bae SC, Joos R, Foeldvari I, Duarte-Salazar C, Wulffraat N, Lahdenne P, Dolezalova P, de Inocencio J, Kanakoudi-Tsakalidou F, Hofer M, Nikishina I, Ozdogan H, Hashkes PJ, Landgraf JM, Martini A, Ruperto N; Pediatric Rheumatology International Trials Organization (PRINTO).

Arthritis Rheum. 2007 Feb 15;57(1):35-43.

32.

Distinct synovial immunopathologic characteristics of juvenile-onset spondylarthritis and other forms of juvenile idiopathic arthritis.

Kruithof E, Van den Bossche V, De Rycke L, Vandooren B, Joos R, Cañete JD, Tak PP, Boots AM, Veys EM, Baeten D.

Arthritis Rheum. 2006 Aug;54(8):2594-604.

33.

Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.

Dewint P, Hoffman IE, Rogge S, Joos R, Union A, Dehoorne J, Delanghe J, Veys EM, De Keyser F, Elewaut D.

Rheumatology (Oxford). 2006 Feb;45(2):204-8. Epub 2005 Sep 27.

PMID:
16188943
34.

A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.

Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S; Pediatric Rheumatology International Trials Organization.

Arthritis Rheum. 2005 Feb;52(2):563-72.

35.

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A; Pediatric Rheumatology International Trials Organization.

Arthritis Rheum. 2004 Jul;50(7):2191-201.

36.

The Belgian-Flemish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).

Joos R, Ruperto N, Wouters C, Boven K, Raat H, Landgraf JM, Veys EM; Paediatric Rheumatology International Trials Organisation.

Clin Exp Rheumatol. 2001 Jul-Aug;19(4 Suppl 23):S20-4.

PMID:
11510325
37.

Occurrence of scleroderma in monozygotic twins.

De Keyser F, Peene I, Joos R, Naeyaert JM, Messiaen L, Veys EM.

J Rheumatol. 2000 Sep;27(9):2267-9.

PMID:
10990246
38.

Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey.

Foeldvari I, Zhavania M, Birdi N, Cuttica RJ, de Oliveira SH, Dent PB, Elborgh R, Falcini F, Ganser G, Girschick H, Häfner R, Joos R, Kuis W, Pelkonen P, Prieur AM, Rostropowicz-Denisiewicz K, Russo R, Savolainen A, Siamopoulou-Mayridou A, Zulian F.

Rheumatology (Oxford). 2000 May;39(5):556-9.

PMID:
10852989
39.

Eosinophilic myositis resulting from sarcocystosis.

Van den Enden E, Praet M, Joos R, Van Gompel A, Gigasse P.

J Trop Med Hyg. 1995 Aug;98(4):273-6.

PMID:
7636925
40.

Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy--a prospective study.

Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, Maertens M, Joos R.

J Rheumatol. 1993 Sep;20(9):1567-72.

PMID:
8164217
41.

Juvenile spondyloarthropathies in 1992.

Veys EM, Mielants H, Joos R, De Clercq L.

J Rheumatol Suppl. 1993 Apr;37:19-24; discussion 24-5. Review.

PMID:
8501746
42.

Sulfasalazine treatment in juvenile chronic arthritis: an open study.

Joos R, Veys EM, Mielants H, van Werveke S, Goemaere S.

J Rheumatol. 1991 Jun;18(6):880-4.

PMID:
1680193
43.

Gold-induced aplastic anemia.

Williame LM, Joos R, Proot F, Immesoete C.

Clin Rheumatol. 1987 Dec;6(4):600-5.

PMID:
3449312
44.

HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation.

Mielants H, Veys EM, Joos R, Noens L, Cuvelier C, De Vos M.

J Rheumatol. 1987 Jun;14(3):466-71.

PMID:
3498033
45.

Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation.

Mielants H, Veys EM, Joos R, Cuvelier C, De Vos M, Proot F.

J Rheumatol. 1987 Jun;14(3):459-65.

PMID:
3498032
46.

Repeat ileocolonoscopy in reactive arthritis.

Mielants H, Veys EM, Joos R, Cuvelier C, De Vos M.

J Rheumatol. 1987 Jun;14(3):456-8.

PMID:
2887654
47.

Significance of gut inflammation in the seronegative spondyloarthropathies.

Mielants H, Veys EM, Cuvelier C, De Vos M, Joos R.

Clin Exp Rheumatol. 1987;5 Suppl 1:S81-7. No abstract available.

PMID:
3652550
48.

Clinical manifestations in HLA-B27-positive patients.

Joos R, Veys EM, Mielants H, Vandewalle K, De Sutter P, Herman H, Poriau S, De Wilde F, Verbruggen G.

Clin Exp Rheumatol. 1987;5 Suppl 1:S41-7.

PMID:
3498598
49.

Familial aggregation in seronegative spondyloarthritis of enterogenic origin. A family study.

Mielants H, Veys EM, Joos R, Suykens S, Cuvelier C, De Vos M.

J Rheumatol. 1986 Feb;13(1):126-8.

PMID:
3701725
50.

Supplemental Content

Support Center